explore -WSS

explore

author：Wikipedia 2025-09-07 21:53:50 - browse：8739

Doctor Monica Bertagnolli, a white woman with short hair and bangs, sits at a hearing behind her name tag — coverage from STAT — National Institutes of Health Director Monica Bertagnolli testifies during her Senate HELP Committee confirmation hearing on Oct. 18 in Washington. Kevin Dietsch/Getty Images

WASHINGTON — The new National Institutes of Health director, Monica Bertagnolli, said it’s a “failure” that enrollment in government-funded clinical trials has lagged behind those funded by the pharmaceutical industry.

“If you just look at the number of patients who go on government-funded trials, it’s been completely flat over the last decade,” she said at a meeting of the advocacy group Friends of Cancer Research. “If you go and look at the number of people who go on pharma-sponsored trials, it’s just this commitment and this increase.”

A Johns Hopkins University study published in 2015 showed that the pharmaceutical industry funds six times more clinical trials than the government. Industry-sponsored trials increased 43% from 2006 to 2014, while newly registered NIH-funded trials decreased 24% over the same period.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： U.K. decision on ALS drug has neurologists, advocates up in arms

WSS

Scientists unlock the key to scar

How to address the problem of discarded donor organs

Covid isolation guidance eased by the CDC

Mass General Brigham physicians react to latest merger step

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Alzheimer's risk factor APOE4 may be a distinct form of the disease

entertainment

explore

explore

In Memoriam: Notable people who died in 2023

U.K. decision on ALS drug has neurologists, advocates up in arms

Alkermes shareholders re

Young boy dies in trial for Pfizer Duchenne gene therapy

Malaria cases in Florida and Texas: Here’s what you need to know

First Opinion on colorectal cancer screening: letter and response

Bright Health sells Medicare Advantage business to Molina

Flu vaccine offering decent levels of protection this winter, new data show

Activists slam private health insurers over coverage restrictions

FDA does about

entertainment

Scientists unlock the key to scar

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

An inside look at PIPEs, biotech's buzzy new financing tool

RSV vaccines may be linked to small increased risk of developing GBS

Congress gives doctors Medicare pay bump

Congress gives doctors Medicare pay bump

hotspot

focus

leisure time

entertainment